On April 11, 2024, Nucleus RadioPharma, Inc. closed the transaction. The company has amended the terms of the transaction. The company has received $10,099,956 in its second and final tranche.

The company has now issued $66,099,955.8874 in the transaction. The transaction included participation from 12 investors pursuant to the exemption provided under regulation D.